| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Clinical diagnosis group: B. Skogseid, A. Beckers, C. Phelan, M. Edwards, M. Epstein, F. Alford, D. Hurley, S. Grimmond, G. Silins, M. Walters, C. Stewart, J. Cardinal, S. Khodaei, F. Parente, L. Tranebjærg, R. Jorde, J. Menon, A. Khir, T. T. Tan, S. P. Chan, A. Zaini, B. A. K. Khalid, K. Sandelin, N. Thompson, M.-L. Brandi, M. Warth, J. Stock, J. Leisti, D. Cameron, J. J. Shepherd, K. Öberg, M. Nordenskjöld and P. Salmela
Endocrine Tumor (B.T.T., S.Ky., F.F., F.K.W., C.L., C.P.) and Clinical Genetics Units (G.W., S.Kh., P.F., and M.N.), Department of Molecular Medicine, Karolinska Hospital, Sweden; Departments of Clinical Genetics (S.Ky., J.L.) and Internal Medicine (P.S.), Oulu University Hospital, Finland; Queensland Institute of Medical Research (L.B., N.H., G.S., M.W., C.S.), Princess Alexandra Hospital (J.C., D.C.), Hunter Area Health Service (M.Ed.); Princeton Medical Centre Hamilton (M.Ep.); Royal Perth Hospital (D.H.); St. Vincents Hospital (F.A.); Royal Hobart Hospital (J.J.S.), Australia; Department of Internal Medicine, Uppsala University Hospital, Sweden (B.S., K.Ö.); Department of Endocrinology, Sart Tilman University Hopital, Liège, Belgium (A.B.); Departments of Medical Genetics (L.T.) and Internal Medicine (R.J.), University Hospital of Tromsø, Norway; Department of Medicine (J.M.), Queen Elisabeth Hospital, Kuta Kinabalu, Sabah, Malaysia; Faculty of Medicine, University of Malaya (A.K., S.P.C., A.Z.), University Kebangsaan Malaysia (T.T.T., B.A.K.K) Kuala Lumpur, Malaysia; University of Michigan Hospital (N.T.), Ann Arbor, Michigan; Department of Clinical Physiopathology (M.-L.B.), University of Florence, Italy; Endocrinology, Memorial Hospital (M.W., J.S.), Worcester, Massachussets
Address all correspondence and requests for reprints to: Catharina Larsson, M.D., Ph.D., Endocrine Tumor Unit, Department of Molecular Medicine, Karolinska Hospital CMM L8:01, S-171 76 Stockholm, Sweden. E-mail: Catharina.Larsson{at}cmm.ki.se
Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant disease characterized by neoplasia of the parathyroid glands, the endocrine pancreas, and the anterior pituitary gland. In addition, families with isolated endocrine neoplasia, notably familial isolated hyperparathyroidism (FIHP) and familial acromegaly, have also been reported. However, whether these families constitute MEN 1 variants or separate entities remains speculative as the genetic bases for these diseases are unclear. The gene for MEN 1 has recently been cloned and characterized. Using single strand conformation analysis (SSCA) and sequencing, we performed mutation analysis in: a) a total of 55 MEN 1 families from 7 countries, b) 13 isolated MEN 1 cases without family history of the disease, c) 8 acromegaly families, and d) 4 FIHP families. Mutations were identified in 27 MEN 1 families and 9 isolated cases. The 22 different mutations spread across most of the 9 translated exons and included frameshift (11), nonsense (6), splice (2), missense mutations (2), and in-frame deletions (1). Among the 19 Finnish MEN 1 probands, a 1466del12 mutation was identified in 6 families with identical 11q13 haplotypes and in 2 isolated cases indicating a common founder. One frameshift mutation caused by 359del4 (GTCT) was found in 1 isolated case and 4 kindreds of different origin and haplotypes; this mutation therefore represents a common "warm" spot in the MEN1 gene. By analyzing the DNA of the parents of an isolated case one mutation was confirmed to be de novo. No mutation was found in any of the acromegaly and small FIHP families, suggesting that genetic defects other than the MEN1 gene might be involved and that additional such families need to be analyzed.
This article has been cited by other articles:
![]() |
S Schaefer, M Shipotko, S Meyer, D Ivan, K J Klose, J Waldmann, P Langer, and P H Kann Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study Eur. J. Endocrinol., May 1, 2008; 158(5): 699 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beckers and A. F Daly The clinical, pathological, and genetic features of familial isolated pituitary adenomas Eur. J. Endocrinol., October 1, 2007; 157(4): 371 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tham, U. Grandell, E. Lindgren, G. Toss, B. Skogseid, and M. Nordenskjold Clinical Testing for Mutations in the MEN1 Gene in Sweden: A Report on 200 Unrelated Cases J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3389 - 3395. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Howell, J. W. Cardinal, A.-L. Richardson, O. Gimm, B. G. Robinson, and D. J. Marsh Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism J. Mol. Diagn., November 1, 2006; 8(5): 559 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Daly, M.-L. Jaffrain-Rea, A. Ciccarelli, H. Valdes-Socin, V. Rohmer, G. Tamburrano, C. Borson-Chazot, B. Estour, E. Ciccarelli, T. Brue, et al. Clinical Characterization of Familial Isolated Pituitary Adenomas J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3316 - 3323. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Soares, K. Eguchi, and L. A. Frohman Tumor Deletion Mapping on Chromosome 11q13 in Eight Families with Isolated Familial Somatotropinoma and in 15 Sporadic Somatotropinomas J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6580 - 6587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J W Cardinal, L Bergman, N Hayward, A Sweet, J Warner, L Marks, D Learoyd, T Dwight, B Robinson, M Epstein, et al. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing J. Med. Genet., January 1, 2005; 42(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Carrasco, A. A. Gonzalez, C. A. Carvajal, C. Campusano, E. Oestreicher, E. Arteaga, N. Wohllk, and C. E. Fardella Novel Intronic Mutation of MEN1 Gene Causing Familial Isolated Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4124 - 4129. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ebeling, O. Vierimaa, S. Kytola, J. Leisti, and P. I. Salmela Effect of Multiple Endocrine Neoplasia Type 1 (MEN1) Gene Mutations on Premature Mortality in Familial MEN1 Syndrome with Founder Mutations J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3392 - 3396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Warner, M Epstein, A Sweet, D Singh, J Burgess, S Stranks, P Hill, D Perry-Keene, D Learoyd, B Robinson, et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications J. Med. Genet., March 1, 2004; 41(3): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Simonds, C. M. Robbins, S. K. Agarwal, G. N. Hendy, J. D. Carpten, and S. J. Marx Familial Isolated Hyperparathyroidism Is Rarely Caused by Germline Mutation in HRPT2, the Gene for the Hyperparathyroidism-Jaw Tumor Syndrome J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
V M Howell, C J Haven, K Kahnoski, S K Khoo, D Petillo, J Chen, G J Fleuren, B G Robinson, L W Delbridge, J Philips, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours J. Med. Genet., September 1, 2003; 40(9): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dwight, A. E. Nelson, G. Theodosopoulos, A. L. Richardson, D. L. Learoyd, J. Philips, L. Delbridge, J. Zedenius, B. T. Teh, C. Larsson, et al. Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparathyroidism Am. J. Pathol., October 1, 2002; 161(4): 1299 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okamoto, A. Tamada, N. Hai, M. Doi, I. Uchimura, Y. Hirata, and S. Kosugi A Novel Six-nucleotide Insertion in Exon 4 of the MEN1 Gene, 878insCTGCAG, in Three Patients with Familial Insulinoma and Primary Hyperparathyroidism Jpn. J. Clin. Oncol., September 1, 2002; 32(9): 368 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kouvaraki, J. E. Lee, S. E. Shapiro, R. F. Gagel, S. I. Sherman, R. V. Sellin, G. J. Cote, and D. B. Evans Genotype-Phenotype Analysis in Multiple Endocrine Neoplasia Type 1 Arch Surg, June 1, 2002; 137(6): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Brandi, R. F. Gagel, A. Angeli, J. P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R. G. Gheri, A. Libroia, et al. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5658 - 5671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Guo and M. P. Sawicki Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1 Mol. Endocrinol., October 1, 2001; 15(10): 1653 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hai, G. Muto, H. Okamoto, A. Tamada, R. Abe, S. Suzuki, and S. Kosugi A Novel Germline Mutation of the MEN1 Gene, L259del, in a Patient with Sporadic Multiple Endocrine Neoplasia Type 1 (MEN1) Jpn. J. Clin. Oncol., March 1, 2001; 31(3): 125 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S KYTÖLÄ, A VILLABLANCA, T EBELING, B NORD, C LARSSON, A HÖÖG, F K WONG, M VÄLIMÄKI, O VIERIMAA, B T TEH, et al. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland J. Med. Genet., March 1, 2001; 38(3): 185 - 189. [Full Text] |
||||
![]() |
B. H. Jorge, S. K. Agarwal, V. S. Lando, R. Salvatori, R. R. Barbero, N. Abelin, M. A. Levine, S. J. Marx, and S. P. A. Toledo Study of the Multiple Endocrine Neoplasia Type 1, Growth Hormone-Releasing Hormone Receptor, Gs{{alpha}}, and Gi2{{alpha}} Genes in Isolated Familial Acromegaly J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 542 - 544. [Abstract] [Full Text] |
||||
![]() |
T. Abe, K. Yoshimoto, M. Taniyama, K. Hanakawa, H. Izumiyama, M. Itakura, and K. Matsumoto An Unusual Kindred of the Multiple Endocrine Neoplasia Type 1 (MEN1) in Japanese J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1327 - 1330. [Full Text] |
||||
![]() |
M. R. Gadelha, K. N. Une, K. Rohde, M. Vaisman, R. D. Kineman, and L. A. Frohman Isolated Familial Somatotropinomas: Establishment of Linkage to Chromosome 11q13.1-11q13.3 and Evidence for a Potential Second Locus at Chromosome 2p16-12 J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 707 - 714. [Abstract] [Full Text] |
||||
![]() |
E. Edstrom, E. Mahlamaki, B. Nord, M. Kjellman, R. Karhu, A. Hoog, N. Goncharov, B. T. Teh, M. Backdahl, and C. Larsson Comparative Genomic Hybridization Reveals Frequent Losses of Chromosomes 1p and 3q in Pheochromocytomas and Abdominal Paragangliomas, Suggesting a Common Genetic Etiology Am. J. Pathol., February 1, 2000; 156(2): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text] |
||||
![]() |
R. V. Thakker Editorial: Multiple Endocrine Neoplasia--Syndromes of the Twentieth Century J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2617 - 2620. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |